From the Analyst's Couch | Published:

The human microbiome: opportunity or hype?

Nature Reviews Drug Discovery volume 16, pages 823824 (2017) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


The authors gratefully acknowledge U. Schulze, A. Farber and V. Panier for their expert reflections on this topic. The authors would also like to thank T. Guez, F. Bellino and M. Fuller for the support on the research and assembly of the report.

Author information


  1. The Boston Consulting Group, 600 Brickell Avenue, Miami, Florida 33131, USA.

    • Pedro M. Valencia
  2. The Boston Consulting Group, Exchange Place, Boston, Massachusetts 02109, USA.

    • Jesse Brock
  3. DBV Technologies, 177–181 Avenue Pierre Brossolette 92120, Montrouge, France.

    • Magali Richard
  4. The Boston Consulting Group, 24–26 Rue Saint-Dominique, 75007 Paris, France.

    • Elsy Boglioli


  1. Search for Pedro M. Valencia in:

  2. Search for Magali Richard in:

  3. Search for Jesse Brock in:

  4. Search for Elsy Boglioli in:

Competing interests

The authors of this article are or were employees of The Boston Consulting Group (BCG), a management consultancy that works with the world's leading biopharmaceutical companies. The research for this specific article was funded by BCG's Health Care practice.

Corresponding author

Correspondence to Elsy Boglioli.

About this article

Publication history



Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing